CLINICAL_TRIALS
trial_result
· 2023-02-08
Clinical Trial Update: Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin [Phase 3]
Summary
Phase 3 trial comparing Meclin (meclizine hydrochloride) to Draminn (dimenhydrinate) for control of acute vertigo of peripheral origin; study completed with non…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apsen Farmaceutica S.A. | Conditions: Vertigo, Peripheral | Phase 3 | Status: COMPLETED